查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1529860

醫用特種袋市場規模、佔有率和趨勢分析報告：按產品、按地區和細分市場預測，2024-2030 年

Medical Specialty Bags Market Size, Share & Trends Analysis Report By Product (Ostomy Collection Bags, Urinary Collection Bags, Blood Bags, Bile Collection Bags, Sterile Packaging Bags), Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

醫療特種袋市場成長與趨勢：

根據Grand View Research, Inc.的最新報告，預計2030年全球醫療特種袋市場規模將達到140.6億美元，預計2023年至2030年複合年成長率為4.4%。

人口老化比例的增加和尿失禁等疾病的流行預計將成為未來七年市場成長的主要驅動力。

旨在透過提高產品成本效益來吸引客戶注意力的政府政策和舉措預計將在預測期內推動需求。合理化報銷政策以提高產品吸引力預計也將在預測期內對醫療特種袋市場的成長發揮重要作用。

可支配收入的增加和對各種疾病的健康意識的提高，加上未滿足的醫療需求不斷增加，再加上巴西、中國和印度等新興國家推出負擔得起的醫療專業包，推動了該行業的發展，預計將推動未來的成長。美國和加拿大醫療設備的高消費稅預計將成為未來七年醫療特種袋市場的主要挑戰。

根據產品類型，醫療專用袋市場細分為尿液收集袋、麻醉呼吸袋、無菌包裝袋、血液袋、膽汁收集袋、屍體袋、造口袋、經腸營養袋、靜脈輸液袋、連續門診袋大致分為腹膜透析袋。 （CAPD）等

醫療專用袋市場報告亮點

  • 造口收集袋在 2013 年成為最大的產品領域，預計 2014 年至 2020 年複合年成長率為 4.3%，達到 29.4 億美元。另一方面，由於微創腹腔鏡膽囊切除術的需求不斷增加，預計2014年至2020年膽汁收集袋將以6.5%的複合年成長率快速成長。
  • 輸液袋市場收益預計到2020年將達到24.699億美元，2014年至2020年複合年成長率為5.2%。醫療專業包由家庭醫療保健和手術中心等細分市場組成。由於需求和客戶意識的增加，像 SurgiCenters 這樣的小型非醫院參與者預計將推動市場成長。這些袋子用於醫院的手術。
  • 由於擁有先進的醫療基礎設施、意識層級的提高以及報銷框架，北美在 2013 年佔據了最大的市場佔有率。這些因素導致了該地區的高利用率和手術量。
  • 亞太地區醫療專用袋市場預計將出現最高成長，2014年至2020年複合年成長率將超過6.0%。醫療知識的不斷成長、醫療保健基礎設施的改善和醫療成本的提高是預計在預測期內實現快速成長的一些因素。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章醫療專用袋市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 醫療專用袋市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • 管道分析

第4章 醫療專用袋市場：依治療方式估算與趨勢分析

  • 全球醫療專用袋市場：按產品分類的儀表板
  • 全球醫療特種袋市場：按產品分類的波動分析
  • 全球醫療特種袋市場：按產品分類的收益
  • 造口收集袋
  • 靜脈 (IV) 輸液袋
  • 連續性攜帶式腹膜透析 (CAPD) 袋
  • 尿液收集袋
  • 無菌包裝袋
  • 麻醉呼吸袋
  • 屍袋
  • 血袋
  • 灌腸袋
  • 經腸營養袋
  • 膽汁收集袋
  • 冰袋

第5章 醫用特種袋市場：區域估算及趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模、預測趨勢分析：
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第6章 競爭狀況

  • 公司/競爭對手分類
  • 供應商情況
    • 主要經銷商及通路夥伴名單
    • 主要客戶
    • 2023年主要企業市場佔有率分析
    • B. Braun SE
    • Baxter
    • Bard
    • Coloplast A/S
    • Convatec Inc.
    • Fresenius Medical Care AG
    • Hollister Incorporated
    • SB-KAWASUMI LABORATORIES, INC.
    • Macopharma
    • Pall Corporation（Danaher）
    • Terumo Corporation
    • Westfield Medical Ltd.
Product Code: 978-1-68038-172-6

Medical Specialty Bags Market Growth & Trends:

The global medical specialty bags market size was estimated at USD 14.06 billion in 2030 and is expected to grow at a CAGR of 4.4% from 2023 to 2030, according to a new report by Grand View Research, Inc. Growing percentage of aging population and prevailing diseases such as urinary incontinence is expected to be the key driving factor for market growth over the next seven years.

Government policies and initiatives intended to draw customer attention by improving the cost-effectiveness of product offering is expected to drive demand over the forecast period. Streamlined reimbursement policies to make the product more attractive is also expected to play a major role in the growth of the medical specialty bag market over the forecast period.

Rise in the disposable income and growing health awareness regarding various diseases coupled with increasing unmet medical needs and the introduction of affordable medical specialty bags in emerging economies such as Brazil, China, and India is anticipated to propel the future growth of the industry. High excise tax rates on healthcare devices in theU.S and Canada is expected to serve as a key challenge for the medical specialty bags market over the next seven years.

Based on the type of product, the medical specialty bag market is broadly classified into urinary collection bags, anesthesia breathing bags, sterile packaging bags, blood bags, bile collection bags, cadaver bags, ostomy bags, enteral feeding bags, intravenous fluid bags, and continuous ambulatory peritoneal dialysis bags. (CAPD).

Medical Specialty Bags Market Report Highlights:

  • Ostomy collection bags was the largest product segment in 2013 and is estimated to grow at a CAGR of 4.3% from 2014 to 2020 to reach USD 2.94 billion. Bile collection bags, on the other hand, are expected to grow at a fast pace with a CAGR of 6.5% from 2014 to 2020, on account of the rising need for minimally invasive laparoscopic cholecystectomy procedures.
  • Intravenous (IV) fluid bags market revenue is estimated to reach USD 2,469.9 million by 2020, growing at a CAGR of 5.2% from 2014 to 2020. Medical specialty bags comprise niche segments including home healthcare and SurgiCenters. Small non-hospital players such as SurgiCenters are expected to drive the market growth owing to increasing demand and customer awareness. These bags are used for surgeries in hospitals.
  • North America accounted for the largest share of the market in 2013 owing to the existence of sophisticated healthcare infrastructure, better patient awareness levels, and reimbursement framework. These elements are responsible for high rates of usage and procedure volumes in the region.
  • Asia Pacific medical specialty bags markets expected to grow at the highest CAGR of over 6.0% from 2014 to 2020. Improved medical knowledge, in addition to improving healthcare infrastructure and disbursements, are some of the factors expected to account for its rapid growth over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Regional scope
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Medical Specialty Bags Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Medical Specialty Bags Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pipeline Analysis

Chapter 4. Medical Specialty Bags Market: Treatment Estimates & Trend Analysis

  • 4.1. Global Medical Specialty Bags Market: Product Dashboard
  • 4.2. Global Medical Specialty Bags Market: Product Movement Analysis
  • 4.3. Global Medical Specialty Bags Market by Product, Revenue
  • 4.4. Ostomy Collection Bags
    • 4.4.1. Ostomy Collection Bags market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Single use
      • 4.4.2.1. Single use market estimates and segment forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Multiple use
      • 4.4.3.1. Multiple use market estimates and segment forecasts 2018 to 2030 (USD Million)
  • 4.5. Intravenous (IV) Fluid Bags
    • 4.5.1. Intravenous (IV) fluid bags market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. PVC
      • 4.5.2.1. PVC market estimates and segment forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Non-PVC
      • 4.5.3.1. Non-PVC market estimates and segment forecasts 2018 to 2030 (USD Million)
  • 4.6. Continuous Ambulatory Peritoneal Dialysis (CAPD) Bags
    • 4.6.1. Continuous ambulatory peritoneal dialysis (CAPD) Bags market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.2. Bags
      • 4.6.2.1. Bags market estimates and segment forecasts 2018 to 2030 (USD Million)
    • 4.6.3. Disposable
      • 4.6.3.1. Disposable market estimates and segment forecasts 2018 to 2030 (USD Million)
    • 4.6.4. Reusable
      • 4.6.4.1. Reusable market estimates and segment forecasts 2018 to 2030 (USD Million)
  • 4.7. Urinary Collection Bags
    • 4.7.1. Urinary collection bags market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Sterile Packaging Bags
    • 4.8.1. Sterile packaging bags market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.9. Anesthesia Breathing Bags
    • 4.9.1. Anesthesia breathing bags market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10. Cadaver (Body) Bags
    • 4.10.1. Cadaver (Body) bags market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.11. Blood Bags
    • 4.11.1. Blood bags market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.12. Enema Bags
    • 4.12.1. Enema bags market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.13. Enteral Feeding Bags
    • 4.13.1. Enteral feeding bags market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.14. Bile Collection Bags
    • 4.14.1. Bile collection bags market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.15. Ice Bags
    • 4.15.1. Ice Bags market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Medical Specialty Bags Market: Regional Estimates & Trend Analysis by Product

  • 5.1. Regional Dashboard
  • 5.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 5.3. North America
    • 5.3.1. U.S.
      • 5.3.1.1. Key country dynamics
      • 5.3.1.2. Regulatory framework/ reimbursement structure
      • 5.3.1.3. Competitive scenario
      • 5.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.2. Canada
      • 5.3.2.1. Key country dynamics
      • 5.3.2.2. Regulatory framework/ reimbursement structure
      • 5.3.2.3. Competitive scenario
      • 5.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.3. Mexico
      • 5.3.3.1. Key country dynamics
      • 5.3.3.2. Regulatory framework/ reimbursement structure
      • 5.3.3.3. Competitive scenario
      • 5.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Key country dynamics
      • 5.4.1.2. Regulatory framework/ reimbursement structure
      • 5.4.1.3. Competitive scenario
      • 5.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Regulatory framework/ reimbursement structure
      • 5.4.2.3. Competitive scenario
      • 5.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. France
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Regulatory framework/ reimbursement structure
      • 5.4.3.3. Competitive scenario
      • 5.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Key country dynamics
      • 5.4.4.2. Regulatory framework/ reimbursement structure
      • 5.4.4.3. Competitive scenario
      • 5.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Key country dynamics
      • 5.4.5.2. Regulatory framework/ reimbursement structure
      • 5.4.5.3. Competitive scenario
      • 5.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.6. Norway
      • 5.4.6.1. Key country dynamics
      • 5.4.6.2. Regulatory framework/ reimbursement structure
      • 5.4.6.3. Competitive scenario
      • 5.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Key country dynamics
      • 5.4.7.2. Regulatory framework/ reimbursement structure
      • 5.4.7.3. Competitive scenario
      • 5.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Key country dynamics
      • 5.4.8.2. Regulatory framework/ reimbursement structure
      • 5.4.8.3. Competitive scenario
      • 5.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework/ reimbursement structure
      • 5.5.1.3. Competitive scenario
      • 5.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.2. China
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.3. India
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Regulatory framework/ reimbursement structure
      • 5.5.3.3. Competitive scenario
      • 5.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Key country dynamics
      • 5.5.4.2. Regulatory framework/ reimbursement structure
      • 5.5.4.3. Competitive scenario
      • 5.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.5. South Korea
      • 5.5.5.1. Key country dynamics
      • 5.5.5.2. Regulatory framework/ reimbursement structure
      • 5.5.5.3. Competitive scenario
      • 5.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.6. Thailand
      • 5.5.6.1. Key country dynamics
      • 5.5.6.2. Regulatory framework/ reimbursement structure
      • 5.5.6.3. Competitive scenario
      • 5.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Key country dynamics
      • 5.6.1.2. Regulatory framework/ reimbursement structure
      • 5.6.1.3. Competitive scenario
      • 5.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.2. Argentina
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework/ reimbursement structure
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. MEA
    • 5.7.1. South Africa
      • 5.7.1.1. Key country dynamics
      • 5.7.1.2. Regulatory framework/ reimbursement structure
      • 5.7.1.3. Competitive scenario
      • 5.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.2. Saudi Arabia
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework/ reimbursement structure
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Regulatory framework/ reimbursement structure
      • 5.7.3.3. Competitive scenario
      • 5.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Regulatory framework/ reimbursement structure
      • 5.7.4.3. Competitive scenario
      • 5.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company/Competition Categorization
  • 6.2. Vendor Landscape
    • 6.2.1. List of key distributors and channel partners
    • 6.2.2. Key customers
    • 6.2.3. Key company market share analysis, 2023
    • 6.2.4. B. Braun SE
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Baxter
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Bard
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Coloplast A/S
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Convatec Inc.
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. Fresenius Medical Care AG
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives
    • 6.2.10. Hollister Incorporated
      • 6.2.10.1. Company overview
      • 6.2.10.2. Financial performance
      • 6.2.10.3. Product benchmarking
      • 6.2.10.4. Strategic initiatives
    • 6.2.11. SB-KAWASUMI LABORATORIES, INC.
      • 6.2.11.1. Company overview
      • 6.2.11.2. Financial performance
      • 6.2.11.3. Product benchmarking
      • 6.2.11.4. Strategic initiatives
    • 6.2.12. Macopharma
      • 6.2.12.1. Company overview
      • 6.2.12.2. Financial performance
      • 6.2.12.3. Product benchmarking
      • 6.2.12.4. Strategic initiatives
    • 6.2.13. Pall Corporation (Danaher)
      • 6.2.13.1. Company overview
      • 6.2.13.2. Financial performance
      • 6.2.13.3. Product benchmarking
      • 6.2.13.4. Strategic initiatives
    • 6.2.14. Terumo Corporation
      • 6.2.14.1. Company overview
      • 6.2.14.2. Financial performance
      • 6.2.14.3. Product benchmarking
      • 6.2.14.4. Strategic initiatives
    • 6.2.15. Westfield Medical Ltd.
      • 6.2.15.1. Company overview
      • 6.2.15.2. Financial performance
      • 6.2.15.3. Product benchmarking
      • 6.2.15.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America medical specialty bags market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 4 U.S. medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 5 Canada medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 6 Mexico medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 7 Europe medical specialty bags market, by region, 2018 - 2030 (USD Million)
  • Table 8 Europe medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 9 Germany medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 10 UK medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 11 France medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 12 Italy medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 13 Spain medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 14 Denmark medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 15 Sweden medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 16 Norway medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific medical specialty bags market, by region, 2018 - 2030 (USD Million)
  • Table 18 Asia Pacific medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 19 China medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 20 Japan medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 21 India medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 22 South Korea medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 23 Australia medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 24 Thailand medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 25 Latin America medical specialty bags market, by region, 2018 - 2030 (USD Million)
  • Table 26 Latin America medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 27 Brazil medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 28 Argentina medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 29 MEA medical specialty bags market, by region, 2018 - 2030 (USD Million)
  • Table 30 MEA medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 31 South Africa medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 33 UAE medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 34 Kuwait medical specialty bags market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Medical specialty bags market: market outlook
  • Fig. 14 Medical specialty bags competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Medical specialty bags market driver impact
  • Fig. 18 Medical specialty bags market restraint impact
  • Fig. 19 Medical specialty bags market: Product movement analysis
  • Fig. 20 Medical specialty bags market: Product outlook and key takeaways
  • Fig. 21 Ostomy collection bags market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Single use market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Multiple use market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Intravenous (IV) fluid bags market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 PVC market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Non-PVC market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Continuous ambulatory peritoneal dialysis (CAPD) bags market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Disposable market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Reusable market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Resuscitation bags market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Urinary collection bags market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Sterile packaging bags market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Anesthesia breathing bags market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Cadaver (Body) bags market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Blood bags market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Enema bags market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Enteral feeding bags market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Bile collection bags market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Ice bags market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Global Medical specialty bags market: Regional movement analysis
  • Fig. 41 Global Medical Specialty Bags market: Regional outlook and key takeaways
  • Fig. 42 Global Medical Specialty Bags market share and leading players
  • Fig. 43 North America, by country
  • Fig. 44 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 U.S. key country dynamics
  • Fig. 46 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Canada key country dynamics
  • Fig. 48 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Mexico key country dynamics
  • Fig. 50 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 UK key country dynamics
  • Fig. 53 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Germany key country dynamics
  • Fig. 55 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 France key country dynamics
  • Fig. 57 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Italy key country dynamics
  • Fig. 59 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Spain key country dynamics
  • Fig. 61 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Denmark key country dynamics
  • Fig. 63 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Sweden key country dynamics
  • Fig. 65 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Norway key country dynamics
  • Fig. 67 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 China key country dynamics
  • Fig. 70 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Japan key country dynamics
  • Fig. 72 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 India key country dynamics
  • Fig. 74 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Thailand key country dynamics
  • Fig. 76 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 South Korea key country dynamics
  • Fig. 78 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Australia key country dynamics
  • Fig. 80 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Brazil key country dynamics
  • Fig. 83 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Argentina key country dynamics
  • Fig. 85 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 South Africa key country dynamics
  • Fig. 88 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Saudi Arabia key country dynamics
  • Fig. 90 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 UAE key country dynamics
  • Fig. 92 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Kuwait key country dynamics
  • Fig. 94 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Market share of key market players- medical specialty bags market